metformin has been researched along with Non-communicable Chronic Diseases in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassano, V | 1 |
| Tallarico, M | 1 |
| Armentaro, G | 1 |
| De Sarro, C | 1 |
| Iannone, M | 1 |
| Leo, A | 1 |
| Citraro, R | 1 |
| Russo, E | 1 |
| De Sarro, G | 1 |
| Hribal, ML | 1 |
| Sciacqua, A | 1 |
| Berstein, LM | 1 |
2 other studies available for metformin and Non-communicable Chronic Diseases
| Article | Year |
|---|---|
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Encephalitis; Metformin; Noncommunicable Disease | 2022 |
[Family diabetes and main noncommunicable diseases: The described and potential effect of metformin (remembering Vladimir Dilman).]
Topics: Diabetes Mellitus, Type 2; Geriatrics; Humans; Hypoglycemic Agents; Male; Metformin; Noncommunicable | 2020 |